Literature DB >> 19283241

HPV vaccination catch up program - utilisation by young Australian women.

Edith Weisberg1, Deborah Bateson, Kirsten McCaffery, S Rachel Skinner.   

Abstract

BACKGROUND: The quadrivalent human papilloma virus (HPV) vaccine provides protection against HPV types 6 and 11, and 16 and 18. The Australian Government's offer of free vaccination to women aged 18-26 years of age through general practitioners ends 30 June 2009.
OBJECTIVE: To determine the percentage of women attending Family Planning New South Wales (FPNSW) clinics aged 26 years or less who were aware of the free HPV vaccination program and had received a full course of the vaccine or had at least one injection.
METHOD: A questionnaire to assess knowledge, attitudes, awareness and utilisation of the free vaccination catch up program for women aged 26 years or less through GPs was given to women attending the Ashfield, Newcastle and Penrith FPNSW clinics during May and June 2008 by the clinic receptionist for completion before seeing the clinician.
RESULTS: Two hundred and ninety-four women aged 15-26 years (mean age 21.7 +/- 2.8) completed the questionnaire out of a total of 512 women in that age group who visited a FPNSW clinic; response rate 57.4%. Eightythree percent had heard about the vaccine and 56% had presented to a GP for at least one injection. The majority of women (213, 72.4%) had visited a GP in the previous 6 months. In total, GPs had suggested having the vaccine to 110 (37.4%) women during a recent visit; 59 (53.6%) of these women had visited a GP specifically to have the HPV vaccine. Of the 179 who responded to the question about awareness of the availability of a free course of HPV vaccine, 76 (42.5%) were unaware that they could obtain free vaccination through a GP.
CONCLUSION: General practitioners should use opportunistic visits by young women to provide information about the catch up HPV vaccination program and encourage them to participate in the program. As the offer of free vaccination through GPs ends 30 June 2009 it is important that GPs encourage as many eligible women as possible to participate. The reduction in incidence of cervical cancer in Australia depends on maximal coverage of eligible women.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19283241

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  9 in total

1.  Factors involved in human papillomavirus (HPV) vaccine hesitancy among women in the South-East Asian Region (SEAR) and Western Pacific Region (WPR): A scoping review.

Authors:  Diviya Santhanes; Che Pui Wong; Yan Ye Yap; Saw Pui San; Nathorn Chaiyakunapruk; Tahir Mehmood Khan
Journal:  Hum Vaccin Immunother       Date:  2017-11-17       Impact factor: 3.452

2.  HPV vaccination and the effect of information framing on intentions and behaviour: an application of the theory of planned behaviour and moral norm.

Authors:  Ilona Juraskova; Michaeley O'Brien; Barbara Mullan; Royena Bari; Rebekah Laidsaar-Powell; Kirsten McCaffery
Journal:  Int J Behav Med       Date:  2012-12

Review 3.  Cervical cancer prevention: new tools and old barriers.

Authors:  Isabel C Scarinci; Francisco A R Garcia; Erin Kobetz; Edward E Partridge; Heather M Brandt; Maria C Bell; Mark Dignan; Grace X Ma; Jane L Daye; Philip E Castle
Journal:  Cancer       Date:  2010-06-01       Impact factor: 6.860

4.  Cost analysis of Human Papillomavirus-related cervical diseases and genital warts in Swaziland.

Authors:  Themba G Ginindza; Benn Sartorius; Xolisile Dlamini; Ellinor Östensson
Journal:  PLoS One       Date:  2017-05-22       Impact factor: 3.240

Review 5.  2. How is the economic assessment of vaccines performed today?

Authors:  Baudouin Standaert; Rino Rappuoli
Journal:  J Mark Access Health Policy       Date:  2017-08-31

6.  Gender and Sexual Orientation Differences in Human Papillomavirus (HPV) Vaccine Uptake among Chinese Young Adults.

Authors:  Edmond Pui Hang Choi; Janet Yuen Ha Wong; Angel Yin Yim Lau; Daniel Yee Tak Fong
Journal:  Int J Environ Res Public Health       Date:  2018-05-28       Impact factor: 3.390

7.  Human papillomavirus (HPV) vaccination intent and its associated factors: a study of ethnically diverse married women aged 27 to 45 in Malaysia, a Southeast Asian country.

Authors:  Li Ping Wong; Haridah Alias; Farhana Nishat Seheli; Gregory D Zimet; Zhijian Hu; Yulan Lin
Journal:  Hum Vaccin Immunother       Date:  2022-06-17       Impact factor: 4.526

8.  Knowledge about HPV, relation between HPV and cervix cancer and acceptance of HPV vaccine in women in eastern region of Turkey.

Authors:  Esra Tonguc; Tayfun Gungor; Turgut Var; Ebru Kavak; Munihe Yucel; Ozlem Uzunlar
Journal:  J Gynecol Oncol       Date:  2013-01-08       Impact factor: 4.401

9.  HPV vaccination in women aged 27 to 45 years: what do general practitioners think?

Authors:  Danielle Mazza; Katja Petrovic; Cathy Grech; Naomi Harris
Journal:  BMC Womens Health       Date:  2014-07-30       Impact factor: 2.809

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.